Understanding what helps and hinders adults who use both e-cigarettes and cigarettes to reduce harm.
Identifying barriers and facilitators of harm reduction among adult dual users of e-cigarettes and cigarettes
['FUNDING_CAREER'] · FLORIDA INTERNATIONAL UNIVERSITY · NIH-11105963
This study is looking at why some adults find it hard to quit smoking when they use both e-cigarettes and regular cigarettes, and it’s for anyone who wants to understand their smoking habits better and find ways to get support in quitting.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FLORIDA INTERNATIONAL UNIVERSITY (nih funded) |
| Locations | 1 site (MIAMI, UNITED STATES) |
| Trial ID | NIH-11105963 on ClinicalTrials.gov |
What this research studies
This research investigates the reasons why some adults who use both e-cigarettes and traditional cigarettes struggle to quit smoking. By using a method called ecological momentary assessment, participants will report their daily experiences and triggers related to smoking over a two-week period. Additionally, focus groups will be held to discuss barriers and facilitators that impact their ability to reduce or quit smoking. The goal is to gather insights that can lead to better support and interventions for these individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who currently use both e-cigarettes and traditional cigarettes.
Not a fit: Patients who exclusively use either e-cigarettes or traditional cigarettes without dual use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for helping adults reduce their tobacco use and improve their overall health.
How similar studies have performed: Previous research has shown that understanding user experiences and barriers can lead to successful interventions in tobacco cessation, making this approach promising.
Where this research is happening
MIAMI, UNITED STATES
- FLORIDA INTERNATIONAL UNIVERSITY — MIAMI, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: OSIBOGUN, OLATOKUNBO — FLORIDA INTERNATIONAL UNIVERSITY
- Study coordinator: OSIBOGUN, OLATOKUNBO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.